tiprankstipranks
Trending News
More News >
Clinica Baviera, SA (ES:CBAV)
BME:CBAV
Spanish Market
Advertisement

Clinica Baviera (CBAV) Ratios

Compare
4 Followers

Clinica Baviera Ratios

ES:CBAV's free cash flow for Q1 2025 was €1.00. For the 2025 fiscal year, ES:CBAV's free cash flow was decreased by € and operating cash flow was €0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.19 1.28 1.09 1.08 0.97
Quick Ratio
1.19 1.22 1.03 1.02 0.92
Cash Ratio
1.01 0.18 0.47 0.28 0.33
Solvency Ratio
0.53 0.61 0.54 0.53 0.36
Operating Cash Flow Ratio
1.26 1.28 1.30 1.33 0.97
Short-Term Operating Cash Flow Coverage
0.00 28.69 26.60 11.42 5.35
Net Current Asset Value
€ -55.82M€ -28.63M€ -37.13M€ -40.49M€ -44.64M
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.27 0.39 0.45
Debt-to-Equity Ratio
0.55 0.52 0.59 0.94 1.23
Debt-to-Capital Ratio
0.36 0.34 0.37 0.49 0.55
Long-Term Debt-to-Capital Ratio
0.05 <0.01 0.04 0.11 0.19
Financial Leverage Ratio
2.09 1.96 2.23 2.45 2.72
Debt Service Coverage Ratio
88.14 20.99 18.81 9.32 4.37
Interest Coverage Ratio
111.96 87.49 99.07 86.03 38.33
Debt to Market Cap
<0.01 <0.01 0.02 0.03 0.07
Interest Debt Per Share
3.87 2.95 2.48 3.19 3.40
Net Debt to EBITDA
0.10 0.58 0.37 0.78 1.29
Profitability Margins
Gross Profit Margin
68.07%87.96%87.15%87.56%87.56%
EBIT Margin
21.14%22.33%20.71%22.81%16.90%
EBITDA Margin
29.08%29.89%28.30%30.97%27.78%
Operating Profit Margin
29.76%22.24%20.91%22.83%16.73%
Pretax Profit Margin
20.62%22.08%20.50%22.52%16.46%
Net Profit Margin
14.64%15.99%14.87%15.86%11.37%
Continuous Operations Profit Margin
14.97%16.33%15.22%16.17%11.36%
Net Income Per EBT
71.00%72.44%72.56%70.41%69.07%
EBT Per EBIT
69.26%99.28%98.04%98.66%98.42%
Return on Assets (ROA)
17.65%20.14%19.67%20.47%11.53%
Return on Equity (ROE)
43.95%39.53%43.83%50.16%31.34%
Return on Capital Employed (ROCE)
46.65%37.50%38.04%39.99%23.15%
Return on Invested Capital (ROIC)
33.88%25.69%25.86%25.70%14.12%
Return on Tangible Assets
21.16%22.30%21.86%23.17%13.18%
Earnings Yield
5.83%9.61%10.38%7.92%6.07%
Efficiency Ratios
Receivables Turnover
28.69 63.15 69.78 51.36 54.12
Payables Turnover
4.04 1.74 1.63 1.66 1.53
Inventory Turnover
0.00 10.95 11.80 11.11 9.29
Fixed Asset Turnover
2.25 2.27 2.31 2.24 1.72
Asset Turnover
1.21 1.26 1.32 1.29 1.01
Working Capital Turnover Ratio
75.73 28.04 63.29 199.59 -14.03
Cash Conversion Cycle
-77.66 -170.17 -187.43 -180.59 -191.76
Days of Sales Outstanding
12.72 5.78 5.23 7.11 6.74
Days of Inventory Outstanding
0.00 33.35 30.94 32.84 39.28
Days of Payables Outstanding
90.38 209.29 223.59 220.54 237.79
Operating Cycle
12.72 39.13 36.17 39.95 46.03
Cash Flow Ratios
Operating Cash Flow Per Share
4.17 3.55 3.27 2.87 1.93
Free Cash Flow Per Share
2.62 2.16 2.41 2.23 1.45
CapEx Per Share
1.56 1.39 0.86 0.65 0.48
Free Cash Flow to Operating Cash Flow
0.63 0.61 0.74 0.77 0.75
Dividend Paid and CapEx Coverage Ratio
1.32 1.62 1.71 1.68 4.02
Capital Expenditure Coverage Ratio
2.68 2.55 3.80 4.43 4.02
Operating Cash Flow Coverage Ratio
1.09 1.22 1.34 0.91 0.57
Operating Cash Flow to Sales Ratio
0.24 0.26 0.27 0.27 0.26
Free Cash Flow Yield
6.00%9.39%13.83%10.50%10.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.15 10.41 9.64 12.62 16.49
Price-to-Sales (P/S) Ratio
2.51 1.66 1.43 2.00 1.87
Price-to-Book (P/B) Ratio
6.32 4.11 4.22 6.33 5.17
Price-to-Free Cash Flow (P/FCF) Ratio
16.65 10.66 7.23 9.53 9.72
Price-to-Operating Cash Flow Ratio
10.45 6.48 5.33 7.38 7.31
Price-to-Earnings Growth (PEG) Ratio
10.80 0.47 1.25 0.13 1.61
Price-to-Fair Value
6.32 4.11 4.22 6.33 5.17
Enterprise Value Multiple
8.73 6.15 5.44 7.24 8.04
Enterprise Value
704.99M 413.47M 305.29M 387.38M 273.86M
EV to EBITDA
8.73 6.15 5.44 7.24 8.04
EV to Sales
2.54 1.84 1.54 2.24 2.23
EV to Free Cash Flow
16.84 11.77 7.76 10.68 11.59
EV to Operating Cash Flow
10.56 7.15 5.72 8.27 8.71
Tangible Book Value Per Share
4.58 4.60 3.27 2.44 1.82
Shareholders’ Equity Per Share
6.89 5.59 4.13 3.35 2.73
Tax and Other Ratios
Effective Tax Rate
0.27 0.26 0.26 0.28 0.30
Revenue Per Share
17.37 13.82 12.17 10.59 7.52
Net Income Per Share
2.54 2.21 1.81 1.68 0.86
Tax Burden
0.71 0.72 0.73 0.70 0.69
Interest Burden
0.98 0.99 0.99 0.99 0.97
Research & Development to Revenue
0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
0.00 0.07 0.09 0.09 0.07
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.25 1.61 1.31 1.20 1.56
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis